Biology of bone cancer pain

Patrick W. O’Donnell, Denis R. Clohisy

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Bone cancer pain is a complex process with many potential targets for therapeutic intervention. As pain is the most common presenting symptom in patients with skeletal metastases and is directly proportional to the patient’s quality of life, clinical advancements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels has shown significant clinical progress in the treatment of cancer-related bone pain. With continued efforts into these and other therapeutic strategies, we hope to continue to improve the quality of life of those patients suffering with bone cancer pain.

Original languageEnglish (US)
Title of host publicationMetastatic Bone Disease
Subtitle of host publicationAn Integrated Approach to Patient Care
PublisherSpringer New York
Pages37-44
Number of pages8
ISBN (Electronic)9781461456629
ISBN (Print)9781461456612
DOIs
StatePublished - Jan 1 2015

    Fingerprint

Keywords

  • Bisphosphonates
  • Bone cancer
  • Denosumab
  • Ion channels
  • Osteoclast
  • Pain
  • Skeletal metastasis

Cite this

O’Donnell, P. W., & Clohisy, D. R. (2015). Biology of bone cancer pain. In Metastatic Bone Disease: An Integrated Approach to Patient Care (pp. 37-44). Springer New York. https://doi.org/10.1007/978-1-4614-5662-9_3